Not direct competitors. NexLife is cash-pay compounded; Form Health is insurance-leveraged MD-led obesity medicine. The right pick depends on your insurance situation.
| Dimension | NexLife | Form Health |
|---|---|---|
| Editorial score | 9.4/10 | 7.8/10 |
| Semaglutide pricing | $145–$165 flat-rate | $135/mo program + meds via insurance |
| Tirzepatide pricing | $186–$215 flat-rate | Insurance only |
Pick NexLife if you're cash-pay (uninsured, high deductible, or excluded coverage). Predictable low cost regardless of plan.
Pick Form Health if you have insurance coverage for GLP-1 medications. Program fee plus copay can be lower than cash-pay compounded.
Most commercial plans cover Ozempic/Mounjaro for T2D; Wegovy/Zepbound for weight is variable.
Yes. Patients often start cash-pay for fast access, then switch to insurance-leveraged once coverage confirmed.
Both. Form Health is MD-led; NexLife discloses Medical Director with physician consults in all 50 states.